Add BrightSurf on Google Email

Emory University Health Sciences Center


Investigational transplant drug effectively preserves kidneys while avoiding toxic side effects

A new investigational transplant drug called LEA29Y has been shown to selectively block the co-stimulatory signal that triggers an immune response, thereby preventing organ rejection and preserving kidney function. This approach avoids the toxic side effects associated with current immunosuppressant medications like cyclosporine.

SourceEmory University Health Sciences Center·JournalAmerican Journal of Transplantation·DateFeb 22, 2005

Mitochondrial DNA mutations play significant role in prostate cancer

Researchers found mitochondrial DNA mutations in 12% of prostate cancer samples and 7.8% of general population controls, with increased tumor growth and oxygen radical production in mutant cells. These findings suggest a causal link between mtDNA mutations and prostate cancer development, particularly in African men.

SourceEmory University Health Sciences Center·JournalProceedings of the National Academy of Sciences·DateJan 14, 2005

Emory biochemist writes lead essay describing Nobel Prize research on ubiquitin protein

Dr. Keith Wilkinson's Nobel Prize-winning research on ubiquitin has provided detailed information about cell survival and death, shedding light on the ubiquitin system's role in regulating protein turnover rates. The discoveries present opportunities to develop highly selective drugs targeting various aspects of the ubiquitin pathway.

Tuberculosis drug combined with virtual reality therapy is effective in treating fear of heights

A study of 28 individuals with acrophobia found that combining D-cycloserine (DCS) with virtual reality exposure therapy significantly reduced fear of heights, with effects lasting at least three months. The treatment works by facilitating 'fear extinction' in the brain, a process previously used to treat phobias and post-traumatic str...

SourceEmory University Health Sciences Center·JournalArchives of General Psychiatry·DateNov 5, 2004

Synthetic hormone used in contraceptives and HRT produces negative effects in monkey studies

Researchers found that estrogen combined with MPA caused increased aggression and anxiety, reduced sexual activity, and altered brain chemistry. The study provides insight into the behavioral effects of HRT and its potential links to depression, anxiety disorders, and premenstrual mood changes.

SourceEmory University Health Sciences Center·JournalThe Journal of Clinical Endocrinology & Metabolism·DateJun 7, 2004